8-K: ACM Research Sells Shanghai Subsidiary Shares

Sentiment:

Share Transfer Announcement


ACM Research, Inc. completed the sale of 4.8 million shares in its Shanghai subsidiary for approximately $110.7 million, reducing its ownership stake to 73.72%.

Capital raiseACM Research, Inc. raised approximately $110.7 million through the sale of 4,801,648 shares of its subsidiary, ACM Research (Shanghai), Inc.The capital was raised via an inquiry-based share transfer plan on the Shanghai Stock Exchange.

Summary

  • ACM Research, Inc. (ACMR US) sold 4,801,648 shares of its operating subsidiary, ACM Research (Shanghai), Inc. (ACM Shanghai).
  • The shares were sold at a price of RMB 160.00 per share, equivalent to approximately $23.05 per share.
  • The total proceeds from the sale are approximately $110.7 million.
  • Following the sale, ACMR US's aggregate ownership percentage in ACM Shanghai decreased from 74.84% to 73.72%.
  • The sale was conducted through an inquiry-based share transfer plan on the Shanghai Stock Exchange.
  • The transfer involved 30 institutional investors, including fund management companies, securities companies, and qualified foreign institutional investors (QFIIs).
  • All transferred shares are subject to a 6-month lock-up period.
  • The change in equity does not result in a change of ACM Shanghai's controlling shareholder or actual controller.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as it successfully raised significant capital for the parent company while maintaining strong majority control over its key operating subsidiary, ACM Shanghai. The dilution is minor and expected in such transactions.

Positives

  • Generated approximately $110.7 million in capital from the sale of 4,801,648 shares.
  • The sale was successfully completed at a preliminarily determined transfer price of RMB 160.00 per share.
  • The transaction attracted a diverse group of 30 institutional investors, indicating market interest in ACM Shanghai.

Negatives

  • ACMR US's ownership percentage in ACM Shanghai decreased from 74.84% to 73.72%, representing a dilution of 1.12%.
  • Previous shareholding reductions by HUI WANG (0.04%) and Jian Wang (0.03%) in November 2025, along with passive dilution from a restricted stock incentive plan, further reduced the collective ownership of ACMR US and its acting-in-concert parties.

Risks

  • Market conditions.
  • Judicial freezing, enforcement, or compulsory disposition of shares.
  • Risks associated with the completion of the sale of shares through the China Securities Depository and Clearing Corporation Limited, Shanghai Branch.
  • Other risks detailed in the Company's periodic reports and other filings with the U.S. Securities and Exchange Commission.

Future Outlook

The filing contains forward-looking statements that involve risks and uncertainties, including market conditions, judicial actions, and the completion process of the share sale. The Company does not intend to revise or update these statements unless required by law.

Management Comments

  • ACMR US warrants that the information provided to ACM Research (Shanghai), Inc. contains no false records, misleading statements or material omissions, and is legally liable for its authenticity, accuracy and completeness thereof in accordance with the law.
  • ACM Shanghai and all members of its Board of Directors hereby warrant that the content of this announcement is consistent with the information provided by the person subject to disclosure obligations.

Industry Context

StockSavvy.ai notes that this share transfer by ACM Research, Inc. in its Shanghai subsidiary reflects a common strategy for foreign-listed companies with significant operations in China. Such transactions can serve to optimize capital structure, increase local market liquidity for the subsidiary, or raise capital for the parent company while maintaining majority control. The participation of numerous institutional investors, including Qualified Foreign Institutional Investors (QFIIs), underscores continued international interest in the Chinese semiconductor sector, despite broader geopolitical tensions.

Comparison to Industry Standards

  • The 6-month lock-up period for transferees is a standard practice in secondary offerings or private placements to prevent immediate selling pressure and promote market stability.
  • The inquiry-based transfer method is a common mechanism on Chinese exchanges like the STAR Market for large block trades, allowing for price discovery among institutional investors.
  • Maintaining majority control (73.72%) after the sale is typical for parent companies seeking to retain strategic influence and consolidate financial results, similar to how Intel maintains a significant stake in Mobileye or how other global tech firms manage their key international subsidiaries.

Related Party Transactions

  • ACMR US, the transferor, is the controlling shareholder of ACM Shanghai and is controlled by HUI WANG, the actual controller and Chairman of ACM Shanghai.
  • ACMR US is acting in concert with HUI WANG and Jian Wang (Director and General Manager of ACM Shanghai).
  • Previous share reductions by HUI WANG and Jian Wang were also noted.

Stakeholder Impact

  • Shareholders (ACMR US): The sale generated significant capital, which could be used for corporate purposes, potentially benefiting shareholders. However, it also resulted in a slight dilution of ownership in a key subsidiary.
  • Shareholders (ACM Shanghai): The introduction of 30 new institutional investors could increase liquidity and broaden the investor base for ACM Shanghai.
  • Management: The transaction maintains the existing control structure, with no change to the controlling shareholder or actual controller of ACM Shanghai.

Next Steps

  • Completion of the sale of the Shares through the China Securities Depository and Clearing Corporation Limited, Shanghai Branch.

Key Dates

DateDescription
2025-11-04HUI WANG began reducing shareholding in ACM Shanghai through centralized bidding transactions.
2025-11-05Jian Wang began reducing shareholding in ACM Shanghai through centralized bidding transactions.
2025-11-07Completion of share registration for the first batch of vested shares under ACM Shanghai's 2023 Restricted Stock Incentive Plan, leading to passive dilution of ACMR US and acting-in-concert parties' shareholding.
2025-11-20HUI WANG completed shareholding reduction in ACM Shanghai.
2025-11-21Jian Wang completed shareholding reduction in ACM Shanghai.
2026-01-30ACM Shanghai issued notice to SSE regarding ACMR US's intent to sell 4,801,648 shares; also the date of issuance of the Subscription Invitation Letter for the Inquiry-Based Transfer.
2026-02-02ACM Shanghai issued notice to SSE announcing RMB 160.00 as the preliminarily determined transfer price per share; valid application period for Subscription Quotation Forms.
2026-02-06ACM Shanghai issued notice to SSE announcing the completion of the sale of 4,801,648 shares at RMB 160.00 per share; effective date of the share transfer.

Recommendation

hold

The successful completion of the share sale is an expected operational event that provides capital to ACM Research, Inc. while maintaining majority control of its key subsidiary. The minor dilution is not significant enough to warrant a 'buy' or 'sell' recommendation based solely on this filing. Investors should 'hold' and monitor how the raised capital is deployed and the ongoing performance of ACM Shanghai.

Keywords

ACM Research, ACMR, ACM Shanghai, Share Sale, Equity Dilution, Shanghai Stock Exchange, Inquiry-Based Transfer, Semiconductor Equipment, China Market, Institutional Investors, Capital Raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.